Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Loos

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The Netherlands Journal of Medicine|October 2, 2001
The (ir)relevance of plasma protein binding of anticancer drugsA Sparreboom, K Nooter, W J Loos, et al.
Anti-Cancer Drugs|July 27, 2000
Determination of camptothecin analogs in biological matrices by high-performance liquid chromatographyW J Loos, P de Bruijn, J Verweij, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urineW J Loos, G Stoter, J Verweij, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 6, 1997
Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatographyW J Loos, J Verweij, K Nooter, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 12, 2000
Liquid chromatographic analysis and preliminary pharmacokinetics of methotrexate in cancer patients co-treated with docetaxelA Sparreboom, W J Loos, K Nooter, et al.
Anti-Cancer Drugs|March 23, 2001
Modulation of camptothecin analogs in the treatment of cancer: a reviewD F Kehrer, O Soepenberg, W J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Topotecan lacks third space sequestrationH Gelderblom, W J Loos, J Verweij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimensW J Loos, H Gelderblom, A Sparreboom, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1997
Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detectionP de Bruijn, J Verweij, W J Loos, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 14, 1998
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA Sparreboom, P de Bruijn, K Nooter, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The Netherlands Journal of Medicine|October 2, 2001
The (ir)relevance of plasma protein binding of anticancer drugsA Sparreboom, K Nooter, W J Loos, et al.
Anti-Cancer Drugs|July 27, 2000
Determination of camptothecin analogs in biological matrices by high-performance liquid chromatographyW J Loos, P de Bruijn, J Verweij, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urineW J Loos, G Stoter, J Verweij, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 6, 1997
Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatographyW J Loos, J Verweij, K Nooter, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 12, 2000
Liquid chromatographic analysis and preliminary pharmacokinetics of methotrexate in cancer patients co-treated with docetaxelA Sparreboom, W J Loos, K Nooter, et al.
Anti-Cancer Drugs|March 23, 2001
Modulation of camptothecin analogs in the treatment of cancer: a reviewD F Kehrer, O Soepenberg, W J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Topotecan lacks third space sequestrationH Gelderblom, W J Loos, J Verweij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimensW J Loos, H Gelderblom, A Sparreboom, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1997
Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detectionP de Bruijn, J Verweij, W J Loos, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 14, 1998
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA Sparreboom, P de Bruijn, K Nooter, et al.
Pageof 7